SCHEMBL30691590

SCHEMBL30691590

COCOc1cc(Cl)nc2c(Cl)csc12

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GRM5 P41594 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22346470 0.71 SMN1; SMN2 (0.31) —
SCHEMBL30691607 0.71 ALDH1A1 (0.33) ALDH1A1
SCHEMBL30691793 0.67 NQO2 (0.33) NQO2
SCHEMBL18768220 0.67 LMNA (0.38) ALDH1A1
SCHEMBL31297569 0.63 SMN1; SMN2 (0.42) ALDH1A1
SCHEMBL20642467 0.63 DHFR (0.36) ALDH1A1
SCHEMBL28555443 0.62 S1PR4 (0.41) ALDH1A1
SCHEMBL13313436 0.61 NQO2 (0.46) NQO2ALDH1A1
SCHEMBL358314 0.60 KDM4E (0.37) —
SCHEMBL18768221 0.60 LMNA (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119997954-A Compounds for the treatment of spinocerebellar ataxia type 3 PTC医疗公司 2025-05-13 — — CN disclosed
EP-4543444-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 PTC Therapeutics, Inc. (US) 2025-04-30 — — EP disclosed
WO-2023250316-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 PTC THERAPEUTICS, INC. (US) 2023-12-28 — — WO disclosed
Send feedback